In In the Pipeline - Posted 5 days ago

Well, since last week around here we were talking about how (and how not to) fund research, I should mention that Bill Gates is currently having some ...

Tags: disease health

In SeekingAlpha Biotech Stocks - Posted 5 days ago

On May 13, 2008, I wrote about the likelihood of Myriad Genetics (MYGN) Flurizan failing its phase III clinical studies for Alzheimer's disease. ...

Tags: disease phase

In SeekingAlpha Biotech Stocks - Posted 5 days ago

On May 31st, AMAG Pharmaceutical (AMAG) announced results from a randomized phase III study of Ferumoxytol, an intravenous [IV] iron replacement thera...

Tags: disease phase

In Health Business Blog - Posted 5 days ago

From the New York Times (Google Tries Tighter Aim for Web Ads)Google, with its deep reservoir of data about online behavior gathered by tracking hundr...

Tags: disease health

In Philly Pharm Bio Blog - Posted 6 days ago

I don't know what to think about this...let the hype begin...A British woman has made history by conceiving the country's first designer baby guaran...

Tags: disease

In Sciencebase Science Blog - Posted 6 days ago

Since tetrachloromethane is banned as an industrial solvent avoiding its formation as a byproduct of other chlorocarbons is important, this week, The ...

Tags: disease

In Sciencebase Science Blog - Posted 1 week ago

Genetic disease is a complicated affair. Scientists have spent years trying to find genetic markers for diseases as diverse as asthma, arthritis and c...

Tags: disease environmental genetic health protein

In Health Business Blog - Posted 1 week ago

The latest version of the Health Wonk Review is up at Disease Management Care Blog....

Tags: disease health

In Sciencebase Science Blog - Posted 1 week ago

I m not entirely convinced that bird flu (avian influenza) is going to be the next big emergent disease that will wipe out thousands, if not million...

Tags: disease environmental

In Zacks Equity Research Analyst Blog - Posted 1 week ago

ViroPharma could be a dramatically different-looking company in 2010 if pipeline antiviral candidate Camvia succeeds in treating cytomegalovirus disea...

Tags: disease pipeline

Featured Investment Blogs